Q1 Earnings Forecast for Immunome Issued By Lifesci Capital
Immunome, Inc. (NASDAQ:IMNM – Free Report) – Lifesci Capital issued their Q1 2025 earnings estimates for shares of Immunome in a report released on Tuesday, March 11th. Lifesci Capital analyst C. Zhu expects that the company will post earnings of ($0.61) per share for the quarter. Lifesci Capital currently has a “Outperform” rating and a […]
